Acadian Asset Management LLC Aeterna Zentaris Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 08, 2019
SELL
$2.04 - $5.43 $341,132 - $908,015
-167,222 Closed
0 $0
Q1 2019

May 09, 2019
BUY
$3.03 - $4.65 $370,184 - $568,104
122,173 Added 271.2%
167,222 $777,000
Q4 2018

Feb 07, 2019
BUY
$1.3 - $3.87 $12,532 - $37,306
9,640 Added 27.22%
45,049 $133,000
Q2 2018

Jul 24, 2018
BUY
$1.19 - $2.62 $42,136 - $92,771
35,409 New
35,409 $69,000

About Aeterna Zentaris Inc.

AEZS Quotes by TradingView
  • Ticker AEZS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,855,880
  • Market Cap $19.4M
  • Description
  • Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...
More about AEZS
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email